MyMD Pharmaceuticals Inc

General ticker "MYMD" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $4.0M

MyMD Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -33.9%.

Estimated limits based on current volatility of 1.9%: low 1.81$, high 1.88$

Factors to consider:

  • Earnings for 15 months up through Q1 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [12.01$, 49.76$]
  • 2023-12-31 to 2024-12-30 estimated range: [4.74$, 19.49$]

Financial Metrics affecting the MYMD estimates:

  • Negative: Non-GAAP EPS of -11.40 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: negative Net Income
  • Negative: Operating Cash Flow per share of -9.48 <= 0.20
  • Negative: Industry Operating Cash Flow per share (median) of -0.72 <= 0.28
  • Negative: Industry Earnings per Price (median) of -0.21 <= 0.01
  • Negative: Industry Operating Income to Revenue ratio (median) of -0.78 <= 0.02

Similar symbols

Short-term MYMD quotes

Long-term MYMD plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $9.49MM $28.81MM $15.28MM
Operating Income $-9.49MM $-28.81MM $-15.28MM
Non-Operating Income $0.00MM $-1.08MM $0.09MM
Interest Expense $0.00MM $0.61MM $0.00MM
R&D Expense $2.47MM $6.75MM $9.07MM
Income(Loss) $-9.49MM $-29.89MM $-15.20MM
Taxes $1.19MM $-0.01MM $-0.09MM
Profit(Loss) $-10.68MM $-29.88MM $-15.11MM
Stockholders Equity $34.58MM $23.65MM $14.70MM
Assets $36.84MM $24.81MM $17.54MM
Operating Cash Flow $-11.92MM $-19.52MM $-12.27MM
Investing Cash Flow $-8.76MM $19.85MM $6.91MM
Financing Cash Flow $38.67MM $0.07MM $5.55MM
Earnings Per Share* $-90.86 $-25.60 $-11.68

* EPS are Split Adjusted, recent splits may be reflected with a delay.